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Chandipura virus (CHPV) has recently emerged as an extremely lethal human 
pathogen in the family Rhabdoviridae and is linked to significant encephalitis outbreaks 
in different parts of India. The biology of CHPV remains less studied to date and the 
availability of reagents such as purified proteins can enhance research in this direction. In 
this study, we have overexpressed four of the CHPV proteins namely Nucleoprotein (N), 
Phosphoprotein (P), Matrix protein (M) and Glycoprotein (G) using three distinct tags in 
bacterial system and with changes in inducer concentration, growth and solubilisation 
conditions successfully purified M and G proteins for the first time along with N and P.  
Furthermore, the interactions of CHPV M protein with other viral proteins (G, N and P) 
was investigated using ELISA and GST pull down assays to show the utility of 
solubilised proteins. The results of both the assays demonstrated that M protein interacts 
with both G and N proteins, while it does not interact with P protein, in a similar manner 
as reported for Vesicular Stomatitis Virus. 
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Chandipura virus (CHPV), an 
emerging encephalitis-causing human 
pathogen endemic to India belongs to the 
genus Vesiculovirus of the family 
Rhabdoviridae (Chadha et. al., 2005; Tandale 
et. al., 2008).   It is closely related to, but is 
phylogenetically distinct from Vesicular 
Stomatitis Virus (VSV) [the prototype virus 
of the genus Vesiculovirus]. CHPV has been 
found to infect children below the age of 14 
years with significantly high mortality rate 
which vary from 55–75% (Kumar and 
Arankalle, 2010). The genome of CHPV is 
made of a negative sense single stranded 
RNA enwrapped by nucleocapsid protein 
(N protein) in such a way that the genomic 
RNA lies in the lumen which is formed 
between the N and C terminal lobes of the 
N protein. The 11 kb genome codes for five 
different proteins namely nucleocapsid 
protein (N), phosphoprotein (P), matrix 
protein (M), glycoprotein (G) and large 
protein (L) in the form of five monocistronic 
mRNAs (Basak et. al., 2007). The N-RNA 
(Nucleocapsid-RNA) complex is associated 
with the viral RNA dependent RNA 
polymerase (RdRp) which is composed of L 
protein (the catalytic subunit) and 
phosphorylated form of P protein (the 
transcriptional activator) (Basak et. al., 2007; 
Mire et. al., 2009). The L, P and N proteins 
together with the RNA form the 
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ribonucleoprotein (RNP) particle. During 
assembly the M protein associates with the 
RNP and condenses it into a tightly packed 
helix. This condensation results in the 
characteristic bullet shape morphology of 
the virus (Mire et. al., 2009). The M protein 
enclosed RNP is then surrounded by an 
envelope of host origin during budding. 
The envelope contains approximately 400 
trimers of G protein spikes that protrude 
from the virion surface (Mire et. al., 2009). G 
protein is the sole spike protein of CHPV 
that is involved in virus assembly and 
budding. It is a typical type I 
transmembrane protein that is embedded 
into the viral envelope with a short 
cytoplasmic tail, a transmembrane domain 
and a large antigenic ectodomain (Rose and 
Welch, 1980; Rose and Doolittle, 1982). Viral 
entry, a critical step in the life cycle of the 
virus, is mediated by G protein.  
Apart from functioning as a structural 
component, M protein controls the switch 
between viral replication and transcription 
(Finke et. al., 2003; Connor et. al., 2006) by 
condensing the nucleocapsid into a tightly 
coiled helical structure (Newcomb et. al., 
1982). It also promotes viral budding (Harty 
et. al., 1999; Bieniasz, 2006) and modulates 
host transcription (Komarova et. al., 2007) 
and translation (von Kobbe et. al., 2000); 
thus responsible for the cytopathic effects 
(CPE) exhibited by the virus. M protein 
regulates the translation of host mRNA by 
binding to and/or modulating the 
phosphorylation state of translation 
initiation factors (Connor et. al., 2004; 
Komarova et. al., 2007) as well as inducing 
the production of viral proteins through an 
unknown mechanism (Connor et. al., 2006). 
The information related to functions of 
CHPV proteins is hypothesized from 
studies on VSV. Keeping in mind the 
difference in target hosts, lethality of the 
virus and phylogenetic difference between 
CHPV and VSV, there is a requirement to 
get purified proteins from CHPV itself to 
understand its specific biological 
mechanisms. In the current study, we have 
successfully solubilised and purified M and 
G proteins of CHPV using bacterial system 
along with N and P proteins. Significantly, 
purification of G protein using a bacterial 
system has never been reported for any of 
the rhabdoviruses. The proteins discussed 
here are useful in detection and 
confirmation of protein-protein interactions 
and could find usage for antibody 
generation, structural and other biological 
studies. Using ELISA and GST pull down 
based methods, the interactions of M 
protein with other CHPV proteins i.e., G, N 
and P have been probed which highlight 
the utility of reagents described. 
 
MATERIALS AND METHODS 
1. Reagents and Plasmids:  
Clones carrying N, P, M and G genes of 
CHPV were kindly provided by Prof. 
Dhrubajyoti Chattopadhyay of B.C. Guha 
Centre, Kolkatta. 
 
2. PCR amplification and Cloning: 
Genes encoding N, P, M and G proteins of 
CHPV were PCR amplified using gene 
specific primers designed for cloning in 
pGEX4T3 (GST tag; Novagen Biosciences, 
USA), pLTA (His tag), and pCAK (Strep 
tag) vectors. pLTA and pCAK vectors have 
been designed and described earlier by one 
of the authors (Gupta, 2009). pGEX4T3 is a 
high copy number plasmid with ampicillin 
resistance while pLTA and pCAK are low 
copy vectors carrying ampicillin and 
kanamycin resistance genes as selectable 
markers, respectively.  
The primer sequences with 
characteristic restriction site incorporated to 
facilitate cloning are listed in Table 1. PCR 
reaction was performed in a final volume of 
100 µl using 10 pmol of each primer, 1 mM 
dNTPs (Sigma Aldrich, USA), 3.0 U of Taq 
DNA polymerase (Sigma Aldrich, USA), 
Pfu DNA polymerase (Promega, USA) and 
1 ng of template DNA. The products were 
purified using PCR purification kit (Sigma 
Aldrich, USA). For cloning in pLTA and 
pCAK vectors, PCR purified products were 
treated with T4 DNA polymerase and dTTP 
to generate BsaI compatible ends. Bacterial 
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vectors (pCAK and pLTA) were digested 
with BsaI enzyme and gel purified. 
Following ligation, the transformants were 
selected on appropriate antibiotic. For 
cloning in pGEX4T3 vector, the restriction 
enzyme combinations SmaI-XhoI for N and 
P genes and EcoRI-NotI for M and G genes 
were used. The genes and vector were 
digested with the respective enzyme 
combinations and finally ligated to get 
recombinant pGEX4T3 vectors carrying 
viral genes. 
 
Table 1: Primers of CHPV genes for cloning in pGEX4T3, pLTA and pCAK vectors 
S.no Gene ID     Primer Sequence 
1 N F (pLTA & pCAK) 5’  CGGCAGCAGTTCTCAAGTATTCTGCATTT 3’ 
2 N R (pLTA & pCAK) 5’  CTCCACCTCATGCAAAGAGTTTCCTGG  3’ 
3 P F (pLTA & pCAK) 5’  CGGCAGCGAAGACTCGCAACTGTATCAA  3’ 
4 P R (pLTA & pCAK) 5’  CTCCACCTCAATTGAACTGGGGCTCAAG  3’ 
5 M F (pLTA & pCAK) 5’  CGGCAGCCAACGTCTGAAGAAGTTTATAG 3’ 
6 M R (pLTA & pCAK) 5’  CTCCACCTCAATGACTCTTAGAAATCAGC  3’ 
7 G F (pLTA & pCAK) 5’  CGGCAGCACTTCTTCAGTGACAATTAGTGT 3’ 
8 G R (pLTA & pCAK) 5’  CTCCACCTCATACTCTGGCTCTCATGTT  3’ 
9 N F (pGEX4T3) 5’AATCCCCGGGGCAGTTCTCAAGTATTCTGCATTTC3’ 
10 N R (pGEX4T3) 5’ CATCTCGAGTCATGCAAAGAGTTTCCTGGC  3’ 
11 P F (pGEX4T3) 5’ AGAGCCCGGGGCGAAGACTCGCAACTGTATCAA3' 
12 P R (pGEX4T3) 5’    TGCCTCGAGTCAATTGAACTGGGGCTCAAG 3’ 
13 M F (pGEX4T3) 5’ CTCGAATTCCCAACGTCTGAAGAAGTTTATAG 3’ 
14 M R (pGEX4T3) 5’ TGGGCGGCCGCTCAATGACTCTTAGAAATCAGC 3’ 
15 G F (pGEX4T3) 5’ CAGGAATTCCACTTCTTCAGTGACAATTAGTG 3’ 
16 G R (pGEX4T3) 5’ CACGCGGCCGCTCATACTCTGGCTCTCATGTT 3’ 
 
3. Protein Expression and solubilisation: 
All the positive recombinant clones (in 
pGEX4T3, pCAK and pLTA) for each gene 
of CHPV were transformed in BL21 (DE3) 
strain of Escherichia coli to carry out 
expression studies. Transformed cells were 
grown in 30 ml Luria Broth medium 
supplemented with appropriate antibiotic 
(30 µg/ml kanamycin and 100 µg/ml 
ampicillin). The cultures were induced at 
different conditions of temperature, 
induction time and suitable inducer at the 
OD600 value of 0.3. At desired expression 
levels, the cells were harvested by 
centrifugation at 6000 rpm for 6 min at 4 ºC. 
This was followed by cell lysis to obtain 
soluble fractions of fusion proteins by IBA 
Lysis buffer (IBA-GmbH, Germany) 
according to the manufacturer’s protocol. 
Protease inhibitor cocktail (Clontech, USA), 
lysozyme (1µg/ml) and nucleases [DNase 
(20 ng/ml), RNase (6 ng/ml)] were also 
added along with the lysis buffer. The 
soluble and insoluble fractions were 
collected by centrifugation at 13,000 rpm for 
20 min at 4 ºC. The fractions were analysed 
by 10% SDS-PAGE and western blot.  
 
4. Solubilisation of Glycoprotein using 
sarkosyl:  
 G protein, which was insoluble after cell 
lysis was solubilised using sarkosyl, a 
detergent used to solubilise the protein 
from inclusion bodies. Lysis buffer 
containing 50 mM Tris, 5 mM ZnCl2, 300 
mM NaCl, 10 mM β-mercaptoethanol and 
10% sarkosyl was mixed with the pellet 
obtained after lysis and incubated overnight 
at 16 °C. The solubilised protein was then 
recovered as supernatant by centrifugation 
at 13000 rpm for 10 min. The sarkosyl 
concentration was reduced by dialysis in 
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PBS (Phosphate Buffer Saline) at 4 °C. The 
dialysed fraction was then checked for the 
presence of G protein by SDS PAGE 
followed by western blotting using anti-
GST antibody (Sigma Aldrich, USA). 
 
5. Purification of M and G proteins as GST 
fusions and immunoblotting: 
The soluble fraction for M protein and the 
dialyzed sample of G protein were loaded 
on Glutathione sepharose beads (Clontech, 
USA) and incubated at 4 ºC for 2 hours. The 
samples were centrifuged at 2100 rpm for 5 
min at 4 ºC to remove the unbound 
proteins. The beads were washed with PBS 
thrice and subsequently the target proteins 
were eluted from the beads using 10 mM 
reduced Glutathione (Sigma Aldrich, USA) 
at room temperature for 15 min. The eluted 
samples were electrophoresed by 10% SDS-
PAGE and transferred on to the charged 
PVDF (Polyvinylideneflouride) membrane 
(Millipore, USA). The membrane was 
incubated with monoclonal anti-GST 
antibody (Sigma Aldrich, USA); 1:10,000 
dilution for 1 h and subsequently with 
secondary antibody, horseradish peroxidase 
conjugated goat anti-mouse IgG (G 
Biosciences, India); 1:2000 dilution, for 1 h 
at room temperature. The reaction bands 
were developed by 0.05% DAB (Diamino 
Benzidine) and H2O2. The reaction was 
stopped in distilled H2O. 
 
6. ELISA and GST Pull down assays for M 
protein interaction studies: 
For ELISA, Streptactin coated microtiter 
plate (IBA-GmbH, Germany) was incubated 
overnight with M Strep lyaste at 4 ºC. After 
washing with PBST (PBS containing 0.05% 
Tween-20), second lysates of G His, N His 
and P His were loaded on plate for 2 hours 
at 4 ºC. As primary and secondary 
antibodies, anti-His monoclonal antibody at 
1:6000 dilution (Sigma Aldrich, USA) and 
anti-mouse IgG HRP conjugate at 1:4000 
dilution (G Biosciences, India) were used. 
Plate was incubated with both antibodies 
for 1 hr each at room temperature.  After 
each incubation, wells were washed thrice 
with PBST. Finally, 100 µl of substrate 
(TMB, 3,3,5,5-tetramethylbenzidine; Sigma 
Aldrich, USA) was added and reaction 
stopped with 2N HCl.  
For GST pull down assay, M-G, M-N and 
M-P interactions were analysed. The lysates 
of solubilised samples of M GST and G His, 
M GST and N His and M GST and P His 
were mixed and incubated for 2 hours at 4 
ºC. The mixed lysates were then loaded on 
to the Glutathione resin (Clontech, USA) 
and incubated at 4 ºC for 2 hours. Unbound 
protein fraction (flowthrough) was collected 
by centrifugation at 4 ºC/2100 rpm/5 min. 
After 3 washes with 1X PBS, the bound 
proteins were eluted in 10 mM reduced 
Glutathione (Sigma Aldrich, USA) at room 
temperature. Eluted fractions were checked 
for interacting partners by western blot 
analysis with anti-His monoclonal antibody.  
For control, only GST lysate was mixed 
with G His, N His and P His lysates 
respectively and analysed in similar manner 
as tests. 
 
RESULTS AND DISCUSSION 
1. Cloning of CHPV genes in expression 
plasmids: 
All the four genes (N, P, M and G) were 
observed at appropriate sizes (N-1.2 kb, P-
0.8 kb, M-0.69 kb and G-1.5 kb) after PCR 
amplification on 1.2% agarose gel. The 
amplicons were ligated with the digested 
vectors and recombinant plasmids were 
confirmed for cloning by restriction enzyme 
digestion. 
 
2. Overexpression and Solubilisation of 
fusion proteins: 
For solubilisation analysis, we took three 
different tags of varying sizes and 
properties (i.e. GST tag- 220 aa, His tag- 6 aa 
and Strep tag- 8 aa) to check their effect on 
solubilisation of proteins. Conditions such 
as induction temperature, inducer 
concentration and induction time were 
standardized with M protein for every tag 
to increase the solubility (Table 2). For Ara 
promoter of pCAK vector, two different 
concentrations of arabinose 0.2% and 0.5% 
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were checked. At 0.5% arabinose, all the 
four proteins showed suitable expression 
for solubilisation. Similarly, for Tet 
promoter of pLTA vector, three different 
concentrations of anhydrotetracycline 
checked were 20 ng/ml, 50 ng/ml and 100 
ng/ml.  Anhydrotetracycline at 20 ng/ml 
was found to be optimum for solubilisation 
experiments. For Tac promoter of pGEX4T3 
vector, 1 mM IPTG (Isopropyl β-D-
thiogalactopyranoside) was used for 
expression and purification of GST fusion 
proteins. Further these concentrations were 
analyzed at different temperatures (16 ºC, 
25 ºC and 37 ºC) for increasing the soluble 
fraction of proteins. At 37 ºC only N and P 
were found to be soluble. However at 25 ºC 
for 4 hours with all three vector systems, N, 
P and M proteins were soluble i.e., present 
in the supernatant after cell lysis as 
indicated in fig. 1 (Lanes 2, 7 and 9, 
respectively).  Importantly G protein, 
irrespective of all variations and tags, was 
found insoluble (Fig. 1, Lane 4) [data not 
shown for solubilisation of viral proteins 
with pCAK and pLTA vectors]. 
A recently described protocol was 
adopted for G protein solubilisation using 
sarkosyl (Tao et. al., 2010). The insoluble 
pellet of G GST after cell lysis was treated 
with sarkosyl and the solubilised protein 
was purified. The protocol was modified by 
introducing a dialysis step to lower down 
the sarkosyl concentration before 
purification. Using this protocol we were 
able to solubilise all three G GST, G His and 
G Strep fusion proteins (Fig. 3, Lane 2; data 
not shown for G His and G strep). 
 
  
    
Fig. 1:  Solubilisation profile of CHPV proteins: CHPV proteins expressed with GST tag in E. coli 
BL-21 (DE3) cells were checked for solubilisation after cell lysis using IBA lysis buffer. The soluble 
(supernatant, sp) and insoluble (pellet, pl) fractions collected by centrifugation were analysed by 
western blotting using anti-GST monoclonal antibodies. N, P and M proteins were found to be 
partially soluble as they were present partly in the supernatant [lane 2: Nsp, lane 7: Psp, lane: 9 Msp] 
and partly in the cell pellet [lane 1: Npl, lane 6: Ppl, lane: 8 Mpl]. G protein however was found to be 
completely insoluble as it was detected only in the cell pellet (lane 3: Gpl) and not in the supernatant 
(lane 4: Gsp). 
 
Table 2: Different parameters considered for solubilisation analysis of viral proteins. 
 
Parameters GST Tag Strep Tag His Tag 
Inducer IPTG Arabinose Tetracycline 
Inducer Conc. 1 mM 0.20% 
0.50% 
20 ng/ml 
50 ng/ml 
100 ng/ml 
Induction Time 4 hours 2 hours 4 hours 2 hours Overnight 4 hours 2 hours 
Induction Temp 25º C 37º C 25º C 37º C 16º C 25º C 37º C 
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Fig. 2: Purification of CHPV Matrix protein: E. coli BL-21 (DE3) cells transformed with M GST were 
induced with 1mM IPTG for protein expression. Cells were lysed and the soluble fraction 
(supernatant/ cell lysate) was loaded onto the glutathione sepharose beads. After elution of the 
bound protein, samples were then analysed on 10% SDS-PAGE followed by Coomassie Brilliant Blue 
staining. Purified M GST fusion protein was present in the eluted fraction. (lane 2). The unbound 
proteins were present in the flowthrough (lane 1). Lane 3 is the protein ladder (molecular sizes are 
indicated in kDa).  
 
 
 
Fig. 3: Purification of CHPV Glycoprotein: BL-21 (DE3) cells expressing G GST fusion protein were 
lysed and the soluble (supernatant) and insoluble (cell pellet) fractions were collected after 
centrifugation. G GST protein was detected in the insoluble fraction and was solubilised using 
sarkosyl. The solubilised fraction was dialysed and loaded on glutathione sepharose beads. Following 
elution, the samples were analysed by SDS-PAGE. Purified G GST protein was present in the eluate 
(lane 1) and Lane 2 represents the solubilised fraction loaded on glutathione beads for purification. 
Lane 3 is the protein ladder (molecular sizes are indicated in kDa). 
 
3. Purification of M GST and G GST 
fusion protein: 
Having achieved solubilisation of all CHPV 
proteins with different tags, GST fusions of 
M and G were purified using Glutathione 
sepharose beads. The purified (eluted) 
samples were analysed by SDS PAGE 
followed by Coomassie brilliant blue 
staining. Eluted fractions showed a 
prominent band at the size of 52 kDa for M 
GST (Fig. 2, Lane 2) and 92 kDa for G GST 
(Fig. 3, Lane 1).  
Unsuccessful attempt has been reported 
earlier for VSV G protein solubilisation by 
removal of transmembrane domain and by 
using Bacillus subtilis secretion vector 
system (Lundstrom, 1984). Recently G 
protein purification of CHPV has been 
reported from baculovirus expression 
system (Venkateswarlu et. al., 2009) but this 
is for the first time that M and G proteins of 
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CHPV have been purified successfully 
using bacterial system. M protein of VSV, 
however, has been purified earlier as GST 
and His Tag fusion (Glodowski et. al., 2002; 
Connor et. al., 2006).  
 
4. Detection of viral protein interactions 
by ELISA: 
For the detection of interactions between 
viral proteins, solubilised proteins were 
used in ELISA as well as GST pull down 
assays. ELISA was performed to study the 
interactions of M (strep tag) protein with 
other viral proteins i.e., G (His), N (His) and 
P (His). Only M Strep lysate was taken as 
negative control (Fig. 4A, Lane 2). 
Following the incubation of lysates with 
anti His antibodies, the His tagged fusion 
proteins (G, N and P) interacting with Strep 
tagged M protein were detected by the 
addition of the substrate. Development of 
blue colour after substrate addition 
indicated a positive interaction as observed 
for M-G (Fig. 4A, Lane 5) and M-N (Fig. 4A, 
Lane 4) interactions while absence of colour 
for M-P (Fig. 4A, Lane 3) proved them as 
non-interactors. The OD450 values were 
determined after stopping the reaction with 
2N HCl. The OD450 values observed for M-
G, M-N and M-P interactions were 1.6, 1.34 
and 0.06 respectively (Fig. 4B). The 
experiment was performed in duplicate. 
 
 
 
Fig. 4: Validation of CHPV M protein interactions by ELISA: Streptactin coated microtiter plate was 
incubated with M Strep lysate overnight followed by incubation with His fusion proteins (G, N and 
P). After washing with PBST, the interacting His fusion protein bound to M Strep was detected using 
anti His monoclonal antibody The lysate of only M Strep (without any His fusion protein lysate) was 
taken as negative control (Panel A, B: lane 2) while M-P constituted as a negative interaction control 
(Panel A, B: lane 3). Blue colour production after addition of substrate (TMB) indicated a positive 
interaction as observed for M-N (Panel A, B:lane 4) and M-G (Panel A, B:lane 5) interactions. Panel A, 
lane 1 was air blank. Panel B shows the final product after stopping the reaction with HCl in 
corresponding lanes.  
                           
5. Confirmation of protein interactions by 
GST pull down: 
GST pull down was performed to confirm 
the interactions detected by ELISA. The 
lysates taken for the study were G His, N 
His and P His with M GST as test and only 
GST as control. Column containing M GST 
(test) or only GST (control) was prepared 
and allowed to bind with lysates of His 
tagged G, N and P. The interacting proteins 
remained bound to the column while non 
interacting proteins came out in the 
flowthrough (unbound fraction). The 
column was washed and interacting 
proteins were eluted with reduced 
glutathione. The samples were analysed by 
western blotting using anti GST (M GST: 52 
kDa) and anti His (G His: 70 kDa, N His: 48 
kDa, P His: 35 kDa) monoclonal antibodies. 
For M-G interaction, the presence of G His 
(Fig. 5A, Lane 2) band in eluted fraction 
confirmed the interaction among M and G 
proteins. In column containing only GST, 
the G His band was not observed in the 
eluate (Fig. 5A, Lane 1) showing the 
specificity of M-G interaction. The binding 
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of GST and M GST fusions with beads was 
also detected for control purpose (Fig. 5B). 
Similarly, M-N interaction was confirmed 
by presence of N His band in eluted fraction 
(Fig. 5A, Lane 5). In M-P pull down, 
however, P His was not observed in the 
eluted fraction (Fig. 5A, Lane 7) while M 
GST was present in the same eluted fraction 
(Fig. 5B, Lane 7) indicating that M and P 
proteins do not interact. ELISA and pull 
down results confirm M-G and M-N 
interactions and prove M-P to be a non 
interacting pair. 
The observed interactions have also been 
shown in VSV earlier. Interaction of M and 
G proteins in VSV and its indispensable role 
in virus assembly has been demonstrated 
by Lyles and co-workers (Lyles et. al., 1992). 
Later in 1994, Chong and his colleagues 
proved the interaction of VSV matrix 
protein and N protein (Chong and Rose 
1994). Recently, the disruption of this 
interaction was shown to be responsible for 
impaired viral assembly (D’agostino et. al., 
2009).   
            
 
                         1       2       3         4          5         6        7 
 
              
                                                   1          2       3       4        5         6        7 
 
 
Fig. 5: Validation of CHPV M protein interactions by GST Pull down: For GST pull down assay, M 
GST was used as a bait to identify the interacting His tagged protein partners i.e., G, N and P. 
Following incubation, the lysates (M GST with His fusion proteins) were loaded on glutathione 
sepharose beads. The interacting His fusion proteins remained bound to the beads while the non-
interacting partner came out in the flowthrough (unbound fraction). The bound proteins were 
analysed by western blotting using anti His (A) and anti GST (B) monoclonal antibodies. Binding of 
GST with His tagged proteins was taken as negative control (A: lanes 1, 4 and 6).  The assay shows 
that M protein interacts with G and N proteins (A: lanes 2 and 5 respectively) but not with P protein 
(A: lane 7). Eluted fractions of pull down were also analysed for the presence of GST (B: lanes 1, 4 and 
6) and M GST (B: lanes 2, 5 and 7) proteins. Molecular sizes of the protein ladder are indicated in kDa 
(A, B: lane 3).  
 
 
A 
B
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CONCLUSION 
Our work provides the first insight with the 
help of different tags, temperature and 
inducer concentration on the property of 
solubility of CHPV proteins. The benefits of 
having all proteins with different tags along 
with successful solubilisation protocols can 
be utilized for pull down studies, Co-IP 
assays etc., to check and validate protein-
protein interactions in virus–virus and 
virus–host context. The purified fusion 
proteins with small tags can also be used for 
generation of antibodies, creation of 
diagnostics and carrying out other 
functional studies. We have shown the 
utility of solubilized proteins by checking 
the interaction of CHPV matrix protein with 
other viral proteins for the first time using 
pull down and ELISA based methods. 
Furthermore the methods described here 
can be utilized for expression and 
purification of M and G proteins of other 
major viruses of rhabdoviridae family.  
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